Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $178B |
| FY2017, ended Dec 31, 2017 | $196B |
| FY2018, ended Dec 31, 2018 | $202B |
| FY2019, ended Dec 31, 2019 | $237B |
| FY2020, ended Dec 31, 2020 | $236B |
| FY2021, ended Dec 31, 2021 | $257B |
| FY2022, ended Dec 31, 2022 | $275B |
| FY2023, ended Dec 31, 2023 | $254B |
| FY2024, ended Dec 31, 2024 | $268B |
| FY2025, ended Dec 31, 2025 | $301B |
| Trailing 12 months to Apr 3, 2026 (through Q1 FY2026) | $330B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $41.9B |
| FY2017, ended Dec 31, 2017 | $36.2B |
| FY2018, ended Dec 31, 2018 | $34.3B |
| FY2019, ended Dec 31, 2019 | $37.3B |
| FY2020, ended Dec 31, 2020 | $33.0B |
| FY2021, ended Dec 31, 2021 | $38.7B |
| FY2022, ended Dec 31, 2022 | $43.0B |
| FY2023, ended Dec 31, 2023 | $45.8B |
| FY2024, ended Dec 31, 2024 | $47.1B |
| FY2025, ended Dec 31, 2025 | $47.9B |
| Trailing 12 months to Apr 3, 2026 (through Q1 FY2026) | $49.3B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $6.53B | $6.53B |
| FY2017, ended Dec 31, 2017 | $1.25B | $5.29B |
| FY2018, ended Dec 31, 2018 | $6.43B | $6.08B |
| FY2019, ended Dec 31, 2019 | $8.92B | $8.42B |
| FY2020, ended Dec 31, 2020 | $7.75B | $8.67B |
| FY2021, ended Dec 31, 2021 | $9.77B | $11.3B |
| FY2022, ended Dec 31, 2022 | $9.54B | $9.53B |
| FY2023, ended Dec 31, 2023 | $10.7B | $9.75B |
| FY2024, ended Dec 31, 2024 | $10.6B | $4.74B |
| FY2025, ended Dec 31, 2025 | $13.1B | $5.30B |
| Trailing 12 months to Apr 3, 2026 (through Q1 FY2026) | $13.7B | $12.6B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $8.55B |
| FY2017, ended Dec 31, 2017 | $6.10B |
| FY2018, ended Dec 31, 2018 | $9.08B |
| FY2019, ended Dec 31, 2019 | $6.48B |
| FY2020, ended Dec 31, 2020 | $6.79B |
| FY2021, ended Dec 31, 2021 | $9.68B |
| FY2022, ended Dec 31, 2022 | $9.52B |
| FY2023, ended Dec 31, 2023 | $9.37B |
| FY2024, ended Dec 31, 2024 | $10.8B |
| FY2025, ended Dec 31, 2025 | $10.3B |
| Trailing 12 months to Apr 3, 2026 (through Q1 FY2026) | $10.6B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $45.5B |
| FY2017, ended Dec 31, 2017 | $47.4B |
| FY2018, ended Dec 31, 2018 | $43.4B |
| FY2019, ended Dec 31, 2019 | $42.8B |
| FY2020, ended Dec 31, 2020 | $42.8B |
| FY2021, ended Dec 31, 2021 | $42.8B |
| FY2022, ended Dec 31, 2022 | $39.1B |
| FY2023, ended Dec 31, 2023 | $41.7B |
| FY2024, ended Dec 31, 2024 | $44.2B |
| FY2025, ended Dec 31, 2025 | $45.4B |
| Trailing 12 months to Apr 3, 2026 (through Q1 FY2026) | $43.8B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 0.2% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 4.29B |
| FY2017, ended Dec 31, 2017 | 4.27B |
| FY2018, ended Dec 31, 2018 | 4.28B |
| FY2019, ended Dec 31, 2019 | 4.29B |
| FY2020, ended Dec 31, 2020 | 4.31B |
| FY2021, ended Dec 31, 2021 | 4.34B |
| FY2022, ended Dec 31, 2022 | 4.33B |
| FY2023, ended Dec 31, 2023 | 4.31B |
| FY2024, ended Dec 31, 2024 | 4.30B |
| FY2025, ended Dec 31, 2025 | 4.30B |
| Trailing 12 months to Apr 3, 2026 (through Q1 FY2026) | 4.30B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash |
|---|---|---|---|
| FY2016, ended Dec 31, 2016 | $3.68B | $258M | $1.43B |
| FY2017, ended Dec 31, 2017 | $3.68B | $219M | $1.59B |
| FY2018, ended Dec 31, 2018 | $1.91B | $225M | $1.48B |
| FY2019, ended Dec 31, 2019 | $1.10B | $201M | $1.01B |
| FY2020, ended Dec 31, 2020 | $118M | $126M | $647M |
| FY2021, ended Dec 31, 2021 | $111M | $337M | $702M |
| FY2022, ended Dec 31, 2022 | $1.42B | $356M | $837M |
| FY2023, ended Dec 31, 2023 | $2.29B | $254M | $539M |
| FY2024, ended Dec 31, 2024 | $1.79B | $286M | $747M |
| FY2025, ended Dec 31, 2025 | $746M | $279M | $313M |
| Trailing 12 months to Apr 3, 2026 (through Q1 FY2026) | $853M | $272M | $309M |
Valuation
At current price- Market Cap
- $392B
- P/E
- 28.6×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 8.0×
- Price / Book
- 11.7×
- EV / EBITDA
- 27.4×
Growth
Trailing 12 months- Revenue (TTM)
- $49.3B
- Revenue Growth YoY
- 5.1%
- Revenue CAGR 3Y
- 3.7%
- Revenue CAGR 5Y
- 7.7%
- EPS Growth YoY
- 27.7%
- Net Income Growth YoY
- 27.0%
Profitability
Trailing 12 months- Gross Margin
- 61.7%
- Operating Margin
- 29.3%
- Net Margin
- 27.8%
- FCF Margin
- 25.5%
- Return on Equity
- 45.8%
Earnings
Trailing 12 months- Net Income
- $13.7B
- EPS (diluted)
- $3.18
- EBITDA
- $15.5B
- Operating Income
- $14.5B
Balance Sheet
As of Apr 3, 2026- Cash and cash equivalents
- $10.6B
- Total Debt
- $43.8B
- Net Debt
- $33.2B
- Total Assets
- $104B
- Total Liabilities
- $68.5B
- Shareholders' Equity
- $33.6B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $14.6B
- Capital Expenditure
- $2.07B
- Free Cash Flow
- $12.6B
Dividends and risk
Last 12 months- Dividend Yield
- 2.3%
- Dividend / Share
- $2.10
- Beta (5Y)
- 0.32
Every ratio is calculated from the company’s reported figures.